Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction.

Opioids are commonly prescribed to address intense, ongoing pain associated with cancer, as well as long-lasting noncancer-related pain when alternative methods have proven ineffective. Individuals who exhibit both chronic pain and misuse of opioids face a significant danger of experiencing adverse health outcomes and the potential loss of life related to opioid use. Thus, there is a current movement to prescribe naloxone to those considered high-risk for opioid overdose. Naloxone has been explored as an antidote to reverse acute respiratory depression. Conversely, naloxone can give rise to other problems, including hypertension and cardiac arrhythmias. Thus, the importance of nanotechnology-enabled drug delivery strategies and their role in mitigating naloxone side-effects are significant. In this review, we explore the latest advancements in nanotechnology-enabled naloxone and alternative methods for addressing the opioid crisis through the utilization of non-opioid natural alternatives for chronic pain management.

Informations de copyright

© 2024 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare the following competing financial interest(s): M.A. and M.N.V.R.K. are inventors on patent applications related to the technology described in the manuscript licensed to Peroral Biosciences, Inc. M.N.V.R.K. is a non-paid scientific advisory board member of Peroral Biosciences, Inc., and M.A. is a shareholder of Peroral Biosciences, Inc.